This inventor holds 2 USPTO granted patents. Top assignee: University of South Florida. Active years: 2017-2018.
Company Filing History:
Years Active: 2017-2018
Title: Ge Bai: Innovator in Peptide Research
Introduction
Ge Bai is a prominent inventor based in Tampa, FL (US), known for his significant contributions to the field of peptide research. He holds 2 patents that focus on innovative methods and compounds for treating Alzheimer's disease.
Latest Patents
His latest patents involve the development of γ-AApeptides and γ-AApeptide building blocks. These patents detail methods for creating γ-AApeptides and libraries of these peptides. They also include methods for screening the γ-AApeptide libraries for desired peptidomimetic activity. Furthermore, the patents describe γ-AApeptides that act as inhibitors of Aβ peptide aggregation. They outline methods for inhibiting and disassembling Aβ peptide aggregation, as well as methods to reduce the toxicity of Aβ aggregates towards N2a neuroblastoma cells.
Career Highlights
Ge Bai is affiliated with the University of South Florida, where he conducts his research and development work. His innovative approaches have the potential to advance the understanding and treatment of neurodegenerative diseases.
Collaborations
He collaborates with notable colleagues such as Jianfeng Cai and Chuanhai Cao, contributing to a dynamic research environment focused on peptide technology.
Conclusion
Ge Bai's work in peptide research exemplifies the intersection of innovation and healthcare, particularly in the fight against Alzheimer's disease. His contributions are paving the way for future advancements in this critical area of study.